MedTrace Logo

Vapocoolant Analgesia for Breast Lymphoscintigraphy

NCT05744557 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-05-20

No results posted yet for this study

Summary

To learn if applying vapocoolant anesthetic spray ("Nüm") on the surface of the intended injection site will reduce the pain/anxiety associated with breast injections.

Conditions

Interventions

OTHER

num Vapocoolant

Spray will be administered for 4 to 6 seconds from a distance of 3 to 6 inches to desired sites of skin

Sponsors & Collaborators

  • Gilero, LLC

    collaborator UNKNOWN

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Sanjit Tewari, MD · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2025-05-13
Completion
2025-05-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05744557 on ClinicalTrials.gov